Common Infections — MCQs
On this page
A 56-year-old man with a history of injection drug use presents to the Emergency Department with a 4-day history of a painful, swollen right forearm. On examination, there is a 6cm area of erythema, warmth, and induration with purulent discharge from a central puncture site. His temperature is 38.2°C, heart rate 102 bpm, and blood pressure 128/78 mmHg. What is the most appropriate initial management for this patient?
A hospital antimicrobial stewardship committee is reviewing prescribing patterns for surgical prophylaxis. They identify that in colorectal surgery, antibiotic prophylaxis is being continued for an average of 3 days postoperatively. According to UK antimicrobial stewardship principles and current surgical prophylaxis guidelines, what is the recommended maximum duration for surgical antibiotic prophylaxis in clean-contaminated procedures?
A 38-year-old woman presents to her GP with a 2-day history of a tender, warm, erythematous area on her left shin measuring approximately 8cm in diameter. She has no systemic symptoms and observations are normal. She has no known allergies and no significant past medical history. According to current UK antimicrobial guidance, what is the recommended first-line oral antibiotic for this patient?
According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the PRIMARY purpose of the 'Start Smart' component?
A 51-year-old man with well-controlled HIV (CD4 count 580 cells/μL, undetectable viral load on antiretroviral therapy) presents with a 4-day history of a painful abscess in his right axilla. The abscess is 4cm in diameter, fluctuant, with surrounding erythema extending 6cm beyond the abscess margin. He is pyrexial at 38.2°C with a heart rate of 95 bpm and blood pressure 125/78 mmHg. What is the most appropriate management?
A hospital trust implements a new antimicrobial stewardship intervention requiring prescribers to document indication, dose, route, and planned duration with review date for all antibiotic prescriptions. Six months post-implementation, audit data shows: documented indication increased from 45% to 92%, documented review dates increased from 12% to 85%, but average antibiotic duration and defined daily doses (DDDs) per 1000 patient-bed days remained unchanged. What does this data primarily indicate?
A 59-year-old woman with breast cancer receiving chemotherapy (day 12 post-cycle) presents with a 24-hour history of fever (38.8°C) and a painful, erythematous rash on her left lower leg with well-demarcated borders and bullae formation. Her blood results show: WCC 1.2 × 10⁹/L (neutrophils 0.4 × 10⁹/L), CRP 156 mg/L. Blood pressure is 105/65 mmHg, heart rate 108 bpm. What is the most appropriate immediate management?
What is the recommended first-line antibiotic for treatment of acute human bite wound infection according to current UK guidelines?
A 37-year-old man who works as a commercial diver presents with a 10-day history of a slowly progressive, painless nodular lesion on his right hand following a minor abrasion sustained while working underwater in a marine environment. The lesion has a violaceous appearance with some ulceration. He is systemically well. What is the most likely causative organism?
Which of the following prescribing scenarios represents the most significant breach of antimicrobial stewardship principles?
Common Infections UK Medical PG Practice Questions and MCQs
Question 81: A 56-year-old man with a history of injection drug use presents to the Emergency Department with a 4-day history of a painful, swollen right forearm. On examination, there is a 6cm area of erythema, warmth, and induration with purulent discharge from a central puncture site. His temperature is 38.2°C, heart rate 102 bpm, and blood pressure 128/78 mmHg. What is the most appropriate initial management for this patient?
- A. Start oral flucloxacillin and arrange outpatient follow-up
- B. Obtain wound swab, start oral co-amoxiclav, and arrange review in 48 hours
- C. Admit for intravenous flucloxacillin and surgical assessment (Correct Answer)
- D. Perform incision and drainage in the Emergency Department and prescribe oral antibiotics
- E. Obtain blood cultures, start oral linezolid, and arrange outpatient parenteral antimicrobial therapy
Explanation: ***Admit for intravenous flucloxacillin and surgical assessment*** - The patient presents with **systemic inflammatory response syndrome (SIRS)** criteria (fever and tachycardia) and a local infection with **purulent discharge** and **induration**, which strongly suggests an abscess or severe cellulitis, necessitating **inpatient admission** for intravenous antibiotics. - **Injection drug use (IDU)** carries a high risk for deep-seated infections or **abscess formation**; therefore, a **surgical assessment** is critical to determine if operative debridement or wash-out is required to adequately manage the infection. *Start oral flucloxacillin and arrange outpatient follow-up* - Oral therapy is insufficient for patients showing **systemic features** of infection like tachycardia and fever, as it may not reach adequate tissue concentrations quickly enough to combat a severe infection. - Outpatient management is inappropriate due to the **high-risk nature of IDU** and the potential for rapid progression to **sepsis** or necrotizing fasciitis, requiring close inpatient monitoring. *Obtain wound swab, start oral co-amoxiclav, and arrange review in 48 hours* - Waiting 48 hours for review is unsafe given the **systemic signs** (fever, tachycardia) and the risk of underlying **deep tissue involvement** in a drug user, which could rapidly deteriorate. - While **wound swabs** can guide therapy, **oral co-amoxiclav** may not cover common pathogens like MRSA in IDU, and **blood cultures** are more critical for systemic infections. *Perform incision and drainage in the Emergency Department and prescribe oral antibiotics* - While drainage is necessary for purulence, simple **incision and drainage (I&D)** in the ED may be inadequate if there is extensive **induration**, deep abscesses, or fascial involvement requiring formal surgical exploration. - Prescribing **oral antibiotics** alone ignores the need for high-dose **intravenous therapy** recommended for cellulitis with systemic involvement and potential deep-seated infection. *Obtain blood cultures, start oral linezolid, and arrange outpatient parenteral antimicrobial therapy* - While **blood cultures** are appropriate, **oral linezolid** as initial therapy is less standard than intravenous agents in an acute, systemically unwell patient, and its primary use is for MRSA. - **Outpatient parenteral antimicrobial therapy (OPAT)** is typically reserved for stable patients after initial inpatient stabilization, not for acute presentations with **fever and tachycardia** requiring immediate inpatient monitoring.
Question 82: A hospital antimicrobial stewardship committee is reviewing prescribing patterns for surgical prophylaxis. They identify that in colorectal surgery, antibiotic prophylaxis is being continued for an average of 3 days postoperatively. According to UK antimicrobial stewardship principles and current surgical prophylaxis guidelines, what is the recommended maximum duration for surgical antibiotic prophylaxis in clean-contaminated procedures?
- A. Single preoperative dose only
- B. Continued for 24 hours postoperatively (Correct Answer)
- C. Continued for 48 hours postoperatively
- D. Continued for 72 hours postoperatively
- E. Continued until drains are removed
Explanation: ***Continued for 24 hours postoperatively***- Current **antimicrobial stewardship** and **NICE guidelines** state that surgical prophylaxis should rarely exceed a **24-hour duration** to prevent the development of **antimicrobial resistance**.- While a single dose is often preferred, extending prophylaxis up to 24 hours is the maximum recommended limit for **clean-contaminated** procedures like colorectal surgery if repeated doses are deemed necessary.*Single preoperative dose only*- Although a **single preoperative dose** is the gold standard for many procedures, guidelines allow for a duration of up to 24 hours in specific **clean-contaminated** contexts.- This option is technically a goal, but the question asks for the **maximum recommended duration** allowed under stewardship principles before it is considered inappropriate.*Continued for 48 hours postoperatively*- Extending prophylaxis to **48 hours** provides no additional benefit in reducing **surgical site infections (SSI)** and increases the risk of **Clostridioides difficile** infection.- Stewardship principles specifically target the reduction of prophylaxis to under 24 hours to minimize **drug toxicity** and hospital costs.*Continued for 72 hours postoperatively*- A **72-hour** duration is considered therapeutic treatment rather than prophylaxis and is inappropriate for standard postoperative care without evidence of **active infection**.- Prolonged exposure significantly increases the selection pressure for **multidrug-resistant organisms** within the hospital environment.*Continued until drains are removed*- There is no clinical evidence supporting the continuation of antibiotics until **surgical drains** are removed; this practice is discouraged by modern **surgical guidelines**.- Keeping patients on antibiotics based on the presence of drains contributes to unnecessary antimicrobial use and does not prevent **retrograde contamination**.
Question 83: A 38-year-old woman presents to her GP with a 2-day history of a tender, warm, erythematous area on her left shin measuring approximately 8cm in diameter. She has no systemic symptoms and observations are normal. She has no known allergies and no significant past medical history. According to current UK antimicrobial guidance, what is the recommended first-line oral antibiotic for this patient?
- A. Amoxicillin 500mg three times daily
- B. Flucloxacillin 500mg four times daily (Correct Answer)
- C. Clarithromycin 500mg twice daily
- D. Co-amoxiclav 625mg three times daily
- E. Doxycycline 200mg loading dose then 100mg once daily
Explanation: ***Flucloxacillin 500mg four times daily***- **Flucloxacillin** is the first-line treatment for uncomplicated **cellulitis** in patients with no penicillin allergy, offering target coverage against **Staphylococcus aureus** and **Streptococcus pyogenes**.- Per **NICE guidelines**, the standard oral dose for adults is **500mg to 1g** four times daily for a duration of 5 to 7 days.*Amoxicillin 500mg three times daily*- This agent is highly effective against **group A streptococcus** but lacks activity against **Staphylococcus aureus**, which produces beta-lactamases.- It is generally reserved for **erysipelas** where streptococci are the primary pathogen, rather than standard cellulitis.*Clarithromycin 500mg twice daily*- This is a **macrolide** antibiotic used as an alternative first-line option for patients with a **penicillin allergy**.- In this case, the patient has no known allergies, so it is not the initial treatment of choice.*Co-amoxiclav 625mg three times daily*- This is a broad-spectrum antibiotic reserved for **complex cellulitis**, such as infections following **animal/human bites** or facial involvement.- Using it for simple cellulitis unnecessarily increases the risk of **antibiotic resistance** and side effects like C. diff.*Doxycycline 200mg loading dose then 100mg once daily*- **Doxycycline** is recommended as a second-line alternative for patients who are **penicillin-allergic** and cannot tolerate macrolides.- It is not indicated as a first-line therapy for an otherwise healthy patient with no drug allergies.
Question 84: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the PRIMARY purpose of the 'Start Smart' component?
- A. To ensure antibiotics are only prescribed when there is clear evidence of bacterial infection
- B. To promote the use of narrow-spectrum antibiotics as first-line therapy
- C. To ensure appropriate microbiological sampling before starting antibiotics
- D. To initiate prompt, effective antibiotic therapy within one hour for patients with severe sepsis (Correct Answer)
- E. To document clear indication, choice, dose, route and duration for all antibiotic prescriptions
Explanation: ***To initiate prompt, effective antibiotic therapy within one hour for patients with severe sepsis*** - The **Start Smart** component emphasizes the timely initiation of effective treatment, specifically highlighting the **one-hour** window for critically ill patients with severe sepsis. - It prioritizes **initial empirical therapy** based on clinical suspicion to ensure patient survival, with subsequent review in the 'Focus' phase. *To ensure antibiotics are only prescribed when there is clear evidence of bacterial infection* - This is a general overarching principle of **antimicrobial stewardship**, but it is not the primary defining purpose of the 'Start Smart' component itself. - In severe sepsis, 'Start Smart' advocates for **empirical antibiotic therapy** to be initiated rapidly, often before definitive bacterial evidence is available. *To promote the use of narrow-spectrum antibiotics as first-line therapy* - 'Start Smart' often requires the initial use of **broad-spectrum antibiotics** to cover potential life-threatening pathogens in critically ill patients. - The process of **narrowing the antibiotic spectrum** is a key objective of the subsequent 'Then Focus' phase, typically performed after 48-72 hours. *To ensure appropriate microbiological sampling before starting antibiotics* - While obtaining **microbiological cultures** before the first antibiotic dose is a crucial recommended action within the 'Start Smart' framework, it serves as an enabling step. - The primary clinical purpose remains the **prompt delivery** of the antibiotic itself to treat the underlying infection effectively. *To document clear indication, choice, dose, route and duration for all antibiotic prescriptions* - These are essential **documentation standards** and elements of good prescribing practice mandated by the toolkit to ensure clarity, safety, and accountability. - Although vital for **clinical governance** and effective stewardship, they are supportive actions rather than the primary clinical objective of rapid antibiotic initiation that 'Start Smart' focuses on.
Question 85: A 51-year-old man with well-controlled HIV (CD4 count 580 cells/μL, undetectable viral load on antiretroviral therapy) presents with a 4-day history of a painful abscess in his right axilla. The abscess is 4cm in diameter, fluctuant, with surrounding erythema extending 6cm beyond the abscess margin. He is pyrexial at 38.2°C with a heart rate of 95 bpm and blood pressure 125/78 mmHg. What is the most appropriate management?
- A. Incision and drainage alone
- B. Incision and drainage with oral flucloxacillin 500mg four times daily (Correct Answer)
- C. Oral flucloxacillin 1g four times daily without drainage
- D. Admission for intravenous flucloxacillin 2g four times daily and surgical drainage
- E. Oral co-amoxiclav 625mg three times daily and arrange outpatient drainage
Explanation: ***Incision and drainage with oral flucloxacillin 500mg four times daily*** - The patient presents with a **fluctuant abscess** and **significant cellulitis** (erythema >5cm beyond the margin), which requires both **drainage** and **antibiotic therapy**. - Although HIV-positive, his **CD4 count >500** and undetectable viral load allow for outpatient management with oral therapy as he is not severely immunocompromised. *Incision and drainage alone* - While drainage is the primary treatment for an abscess, it is insufficient here due to **systemic features** (fever) and extensive **surrounding cellulitis**. - Guidelines recommend adding antibiotics when there is **erythema >5cm** or signs of systemic illness to prevent further spread. *Oral flucloxacillin 1g four times daily without drainage* - Antibiotics alone cannot penetrate the **fibrous capsule** of a fluctuant abscess effectively; **surgical drainage** is the gold standard of treatment. - Relying solely on medication would likely result in treatment failure and potential worsening of the localized infection. *Admission for intravenous flucloxacillin 2g four times daily and surgical drainage* - **Intravenous therapy** and hospital admission are reserved for patients with severe **sepsis**, rapid progression, or those failing oral therapy. - This patient is hemodynamically stable with a heart rate <100 and a normal blood pressure, making **outpatient management** safe and appropriate. *Oral co-amoxiclav 625mg three times daily and arrange outpatient drainage* - **Flucloxacillin** is the preferred first-line agent for skin and soft tissue infections as it specifically targets **Staphylococcus aureus**. - **Co-amoxiclav** provides unnecessarily broad coverage (including anaerobes and Gram-negatives) which is not typically required for a simple axillary abscess.
Question 86: A hospital trust implements a new antimicrobial stewardship intervention requiring prescribers to document indication, dose, route, and planned duration with review date for all antibiotic prescriptions. Six months post-implementation, audit data shows: documented indication increased from 45% to 92%, documented review dates increased from 12% to 85%, but average antibiotic duration and defined daily doses (DDDs) per 1000 patient-bed days remained unchanged. What does this data primarily indicate?
- A. The intervention was ineffective and should be discontinued
- B. Documentation improved but this has not yet translated to changes in prescribing behavior (Correct Answer)
- C. The hospital's baseline prescribing was already optimal so no reduction is possible
- D. The intervention is working and achieving appropriate antimicrobial stewardship goals
- E. Prescriber engagement with the intervention is insufficient and requires disciplinary action
Explanation: ***Documentation improved but this has not yet translated to changes in prescribing behavior*** - The data shows a significant increase in **process measures** (documentation of indication and review dates), indicating that the structural requirements of the intervention were adopted. - However, the lack of change in **outcome measures** such as **average antibiotic duration** and **Defined Daily Doses (DDDs)** suggests that clinicians are documenting without actually modifying their clinical decision-making or narrowing therapy. *The intervention was ineffective and should be discontinued* - The improvement in documentation rates is a positive **process outcome**, showing that prescribers are engaging with the administrative requirements of the intervention. - A lack of immediate change in **prescribing outcomes** at six months often indicates a need for refinement or additional components to the stewardship program, rather than complete abandonment. *The hospital's baseline prescribing was already optimal so no reduction is possible* - It is highly improbable that antibiotic prescribing was **optimally low** given the initial documentation rates for review dates were only 12%, implying significant room for improvement in prescribing practices. - **Antimicrobial stewardship programs** are typically initiated to address suboptimal prescribing, aiming for reductions in duration and DDDs to minimize resistance. *The intervention is working and achieving appropriate antimicrobial stewardship goals* - While documentation is a component of good stewardship, the ultimate goal is to optimize antibiotic use, which includes reducing **unnecessary prescriptions** and **minimizing overall consumption**. - Since **antibiotic duration** and **DDDs** remained unchanged, the core objective of improving clinical prescribing behavior and reducing **antimicrobial resistance** has not yet been met. *Prescriber engagement with the intervention is insufficient and requires disciplinary action* - The substantial increases in documented indication (from 45% to 92%) and review dates (from 12% to 85%) clearly demonstrate **high prescriber engagement** with the documentation requirements. - The issue is not a lack of engagement with the process, but rather that the documentation itself has not yet translated into desired **changes in clinical practice** regarding antibiotic use.
Question 87: A 59-year-old woman with breast cancer receiving chemotherapy (day 12 post-cycle) presents with a 24-hour history of fever (38.8°C) and a painful, erythematous rash on her left lower leg with well-demarcated borders and bullae formation. Her blood results show: WCC 1.2 × 10⁹/L (neutrophils 0.4 × 10⁹/L), CRP 156 mg/L. Blood pressure is 105/65 mmHg, heart rate 108 bpm. What is the most appropriate immediate management?
- A. Oral flucloxacillin 1g four times daily and close outpatient monitoring
- B. Intravenous flucloxacillin 2g four times daily
- C. Intravenous piperacillin-tazobactam 4.5g three times daily (Correct Answer)
- D. Intravenous co-amoxiclav 1.2g three times daily and gentamicin
- E. Intravenous vancomycin 1g twice daily and metronidazole
Explanation: ***Intravenous piperacillin-tazobactam 4.5g three times daily***- The patient has **neutropenic sepsis**, defined as a temperature >38°C and an absolute neutrophil count (ANC) **<0.5 × 10⁹/L**, which is a medical emergency requiring immediate broad-spectrum antibiotics.- **Piperacillin-tazobactam** (Tazocin) is the first-line empirical monotherapy recommended by guidelines because it provides essential **anti-pseudomonal** coverage and broad-spectrum Gram-positive activity.*Oral flucloxacillin 1g four times daily and close outpatient monitoring*- **Outpatient management** and oral antibiotics are inappropriate for a patient with sepsis symptoms (hypotension, tachycardia) and a neutrophil count this low.- **Oral flucloxacillin** lacks the necessary Gram-negative coverage required to treat empirical neutropenic sepsis.*Intravenous flucloxacillin 2g four times daily*- While suitable for standard cellulitis, flucloxacillin is insufficient for **neutropenic sepsis** as it does not cover **Pseudomonas aeruginosa** or other enteric Gram-negative rods.- Patients on chemotherapy are at high risk for **rapidly progressive infection**, necessitating broader spectrum coverage than what a narrow-spectrum penicillin offers.*Intravenous co-amoxiclav 1.2g three times daily and gentamicin*- This combination is not the gold-standard empirical regimen for neutropenic sepsis and does not provide the reliable **anti-pseudomonal** monotherapy recommended as first-line.- **Gentamicin** is generally avoided as a routine empirical first-line choice in neutropenic sepsis due to risks of **nephrotoxicity** unless there is a specific suspicion of resistant organisms.*Intravenous vancomycin 1g twice daily and metronidazole*- **Vancomycin** lacks coverage for Gram-negative organisms, which are the most life-threatening pathogens in the setting of **neutropenia**.- This regimen would be inadequate as an initial monotherapy; vancomycin is typically reserved for patients who remain **hemodynamically unstable** or have suspected **MRSA** infection after starting first-line agents.
Question 88: What is the recommended first-line antibiotic for treatment of acute human bite wound infection according to current UK guidelines?
- A. Flucloxacillin
- B. Co-amoxiclav (Correct Answer)
- C. Doxycycline
- D. Metronidazole
- E. Ciprofloxacin
Explanation: ***Co-amoxiclav***- **Co-amoxiclav** is the first-line treatment as it provides broad-spectrum coverage against the **polymicrobial flora** of the human mouth, including **aerobes** and **anaerobes**.- It specifically targets organisms like **Eikenella corrodens**, **Streptococcus** species, and **Staphylococcus aureus** which are common in human bite infections.*Flucloxacillin*- While effective against *Staphylococci*, **flucloxacillin** lacks sufficient activity against **Gram-negative aerobes** like *Eikenella corrodens*.- It does not provide the necessary anaerobic coverage required for the complex infections resulting from human bites.*Doxycycline*- **Doxycycline** is typically reserved as an alternative for patients with a **penicillin allergy**, often in combination with metronidazole.- It is not considered first-line therapy according to **UK guidelines** for the initial management of human bite wounds.*Metronidazole*- **Metronidazole** provides excellent coverage for **anaerobes**, but it has no activity against **aerobic bacteria**.- It must be used in combination with other agents and is never appropriate as a **monotherapy** for bite wounds.*Ciprofloxacin*- **Ciprofloxacin** has poor activity against **Gram-positive cocci** (like *Streptococci*) and virtually no activity against **anaerobes**.- It is generally unsuitable for human bite infections unless combined with other specific antibiotics for broader coverage.
Question 89: A 37-year-old man who works as a commercial diver presents with a 10-day history of a slowly progressive, painless nodular lesion on his right hand following a minor abrasion sustained while working underwater in a marine environment. The lesion has a violaceous appearance with some ulceration. He is systemically well. What is the most likely causative organism?
- A. Vibrio vulnificus
- B. Aeromonas hydrophila
- C. Mycobacterium marinum (Correct Answer)
- D. Pseudomonas aeruginosa
- E. Erysipelothrix rhusiopathiae
Explanation: ***Mycobacterium marinum***- This pathogen is a **non-tuberculous mycobacterium** typically associated with exposure to **aquatic environments** (e.g., marine, fresh, aquariums), causing a **slowly progressive**, **painless nodular** or granulomatous lesion.- The classic presentation, often called **"swimming pool granuloma"** or **"fish tank granuloma,"** involves a **violaceous lesion** with potential ulceration, developing after skin trauma in contaminated water.*Vibrio vulnificus*- *Vibrio vulnificus* typically causes **fulminant**, rapidly progressive infections characterized by **severe pain**, **hemorrhagic bullae**, and a high risk of **sepsis**.- These infections are often seen in individuals with **underlying liver disease** or **immunocompromise**, and the onset is usually much faster than the 10-day slow progression described.*Aeromonas hydrophila*- *Aeromonas hydrophila* is typically associated with **freshwater exposure** and causes **rapidly progressive cellulitis** or necrotizing fasciitis, often with an acute onset within 24-48 hours.- The lesion in the question is slowly progressive and occurred in a marine environment, which differentiates it from the typical *Aeromonas* presentation.*Pseudomonas aeruginosa*- *Pseudomonas aeruginosa* can cause skin infections like **folliculitis** (e.g., "hot tub folliculitis") or **ecthyma gangrenosum**, which have different clinical appearances and progression than a slowly enlarging, painless nodule.- While it thrives in moist environments, it is less likely to present as a chronic, **violaceous, ulcerated nodule** following minor trauma in a healthy host compared to *M. marinum*.*Erysipelothrix rhusiopathiae*- *Erysipelothrix rhusiopathiae* causes **erysipeloid**, which is characterized by a **painful**, well-demarcated, purplish-red skin lesion, often with raised borders.- Unlike the painless, nodular lesion described, erysipeloid is typically **painful** and does not usually progress to a chronic ulcerating nodule.
Question 90: Which of the following prescribing scenarios represents the most significant breach of antimicrobial stewardship principles?
- A. Prescribing a 7-day course of antibiotics for cellulitis that improves after 5 days
- B. Continuing empirical broad-spectrum antibiotics despite negative cultures at 72 hours in a clinically improving patient (Correct Answer)
- C. Using intravenous antibiotics for the first 24 hours of severe pneumonia before switching to oral
- D. Prescribing prophylactic antibiotics for a patient with recurrent UTIs and structural urinary tract abnormality
- E. Starting empirical antibiotics before obtaining blood cultures in a patient with suspected sepsis
Explanation: ***Continuing empirical broad-spectrum antibiotics despite negative cultures at 72 hours in a clinically improving patient*** - This represents a failure to **de-escalate** or **focalize** therapy, which is a core pillar of **antimicrobial stewardship** that aims to reduce **antibiotic resistance**. - Systematic review at **48-72 hours** is mandatory; if cultures are negative and the patient is stable, therapy should be narrowed or discontinued to prevent **superinfections** like *C. difficile*. *Prescribing a 7-day course of antibiotics for cellulitis that improves after 5 days* - While shorter courses are increasingly preferred, completing a **7-day course** is a common clinical standard and does not represent a major breach compared to broad-spectrum misuse. - This scenario reflects a minor variation in **treatment duration** rather than a failure of fundamental stewardship principles. *Using intravenous antibiotics for the first 24 hours of severe pneumonia before switching to oral* - This is actually an example of **good stewardship**, demonstrating an appropriate **IV-to-oral switch** once the patient is clinically stable. - Early oral conversion reduces **complications** related to IV lines and decreases **length of hospital stay**. *Prescribing prophylactic antibiotics for a patient with recurrent UTIs and structural urinary tract abnormality* - Antibiotic **prophylaxis** is a recognized strategy in patients with documented **structural abnormalities** who suffer from high morbidity due to recurrent infections. - This is a targeted clinical decision based on **patient-specific risk factors** rather than an indiscriminate misuse of antimicrobials. *Starting empirical antibiotics before obtaining blood cultures in a patient with suspected sepsis* - In **sepsis**, minimizing **time-to-antibiotics** is a critical, life-saving intervention that takes priority over waiting for culture collection in emergent situations. - While obtaining cultures first is ideal, prioritizing **rapid administration** of empirical drugs in hemodynamic instability aligns with **Surviving Sepsis Campaign** guidelines.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free